Molecular docking, 2D-QSAR and ADMET studies of 4-sulfonyl-2-pyridone heterocycle as a potential glucokinase activator
Glucokinase is one of the key enzymes for the management of diabetes mellitus. Although the literature has reported numerous molecules for lowering the blood glucose level, still no single moiety has been developed for the management of diabetes mellitus. So, there is an urgent need for the developm...
Main Authors: | Prateek Sharma, Aman Thakur, Anju Goyal, Ajmer Singh Grewal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Results in Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715623003442 |
Similar Items
-
Molecular docking assessment of pyridone derivatives as glucokinase activators
by: Y. Nanda Kumar, et al.
Published: (2012-10-01) -
Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction
by: Saurabh C. Khadse, et al.
Published: (2019-12-01) -
Decreased expression of hepatic glucokinase in type 2 diabetes
by: Rebecca A. Haeusler, et al.
Published: (2015-03-01) -
Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
by: Ziqi Zhang, et al.
Published: (2023-08-01) -
ATP- and Polyphosphate-Dependent Glucokinases from Aerobic Methanotrophs
by: Alexander S. Reshetnikov, et al.
Published: (2019-02-01)